Publications by authors named "Jim Turpin"

Claim this Profile
B
Beyond 2010: Gaps, Challenges, and Priorities for the Future of Preclinical HIV Preexposure Prophylaxis (PrEP): Summary of the October 20-21, 2009 Workshop.
Fulvia Veronese, Jim A Turpin, Cindra Feuer

AIDS Res Hum Retroviruses· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Multipurpose prevention technologies: call for innovative strategies to address critical priorities and gaps.
Clara Soh, Ariane van der Straten, Anke Hemmerling, Jim A Turpin, Bethany Young Holt

Front Reprod Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment.
Scott Sherrill-Mix, Michelle Yang, Grace M Aldrovandi, Jason M Brenchley, Frederic D Bushman, Jim A Turpin

AIDS Res Hum Retroviruses· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs.
Bethany Young Holt, Jim A Turpin, Joseph Romano

Front Reprod Health· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.
Scott Sherrill-Mix, Kaleigh Connors, Grace M Aldrovandi, Jason M Brenchley, Charles Boucher, Jim A Turpin

AIDS Res Hum Retroviruses· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications".
Mohammad Akbar, Erin Berry-Bibee, Diana L Blithe, Ruth S Day, Alison Edelman, Jim A Turpin

J Clin Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Intersection of Young Age, Mucosal Injury, and HIV Susceptibility.
Kristen A Porter, Jim Turpin, Lisa Begg, Gina Brown, Nahida Chakhtoura

AIDS Res Hum Retroviruses· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.
David N Burns, Cynthia Grossman, Jim Turpin, Vanessa Elharrar, Fulvia Veronese

Curr HIV/AIDS Rep· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.
Joseph Romano, Angela Kashuba, Stephen Becker, James Cummins, Jim Turpin

AIDS Res Hum Retroviruses· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.
Janet M Young, Jim A Turpin, Runa Musib, Opendra K Sharma

AIDS Res Hum Retroviruses· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical microbicides to prevent the transmission of HIV: formulation gaps and challenges.
Jim A Turpin

Drug Deliv Transl Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors.
Jim A Turpin, Marco L Schito, Lisa M Miller Jenkins, John K Inman, Ettore Appella

Adv Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeys.
Marco L Schito, Adam C Soloff, Danielle Slovitz, Anita Trichel, John K Inman, Jim A Turpin

Curr HIV Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.
Brigitte E Beer, Gustavo F Doncel, Fred C Krebs, Robin J Shattock, Patricia S Fletcher, Jim A Turpin

Antimicrob Agents Chemother· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent inhibition of HIV-1 entry by (s4dU)35.
András Horváth, Szilvia Tokés, Tracy Hartman, Karen Watson, Jim A Turpin

Virology· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
Toshiyuki Mori, Barry R O'Keefe, Raymond C Sowder, Scott Bringans, Roberta Gardella, Jim A Turpin

J Biol Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of unique, uncharged thioesters as inhibitors of HIV replication.
Pratibha Srivastava, Marco Schito, Rasem J Fattah, Toshiaki Hara, Tracy Hartman, Jim A Turpin

Bioorg Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional redundancy of the human CCL4 and CCL4L1 chemokine genes.
O M Zack Howard, Jim A Turpin, Robert Goldman, William S Modi

Biochem Biophys Res Commun· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral activity of hop constituents against a series of DNA and RNA viruses.
Victor E Buckwold, Richard J H Wilson, Aysegul Nalca, Brigitte B Beer, Thomas G Voss, Jim A Turpin

Antiviral Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-AIDS agents. 52. Synthesis and anti-HIV activity of hydroxymethyl (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone derivatives.
Lan Xie, Donglei Yu, Carl Wild, Graham Allaway, Jim Turpin

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1.
Xin Chen, Lu Yang, Ning Zhang, Jim A Turpin, Robert W Buckheit

Antimicrob Agents Chemother· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin.
Barry R O'Keefe, Donald F Smee, Jim A Turpin, Carrie J Saucedo, Kirk R Gustafson

Antimicrob Agents Chemother· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.
Jim A Turpin

Expert Rev Anti Infect Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.
Heidi R Bokesch, Barry R O'Keefe, Tawnya C McKee, Lewis K Pannell, Gregory M L Patterson, Jim Turpin

Biochemistry· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model.
Marco L Schito, Atul Goel, Yongsheng Song, John K Inman, Rasem J Fattah, Jim A Turpin

AIDS Res Hum Retroviruses· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis